StemCells, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update

Go back to StemCells, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update

StemCells (STEM) Reports In-Line Q4 EPS

March 23, 2016 4:07 PM EDT

StemCells (NASDAQ: STEM) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $28 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on StemCells (STEM) click here.

... More